274 related articles for article (PubMed ID: 18319307)
21. Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction.
de Carvalho DF; Miranda MC; Gomes LG; Madureira G; Marcondes JA; Billerbeck AE; Rodrigues AS; Presti PF; Kuperman H; Damiani D; Mendonca BB; Bachega TA
Eur J Endocrinol; 2016 Aug; 175(2):107-16. PubMed ID: 27185867
[TBL] [Abstract][Full Text] [Related]
22. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
Helmberg A; Tusie-Luna MT; Tabarelli M; Kofler R; White PC
Mol Endocrinol; 1992 Aug; 6(8):1318-22. PubMed ID: 1406709
[TBL] [Abstract][Full Text] [Related]
23. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.
Speiser PW; Knochenhauer ES; Dewailly D; Fruzzetti F; Marcondes JA; Azziz R
Mol Genet Metab; 2000 Nov; 71(3):527-34. PubMed ID: 11073721
[TBL] [Abstract][Full Text] [Related]
24. Genotype-phenotype associations in non-classical steroid 21-hydroxylase deficiency.
Weintrob N; Brautbar C; Pertzelan A; Josefsberg Z; Dickerman Z; Kauschansky A; Lilos P; Peled D; Phillip M; Israel S
Eur J Endocrinol; 2000 Sep; 143(3):397-403. PubMed ID: 11022183
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of CYP-21 mutations for congenital adrenal hyperplasia in Singapore.
Loke KY; Lee YS; Lee WW; Poh LK
Horm Res; 2001; 55(4):179-84. PubMed ID: 11598371
[TBL] [Abstract][Full Text] [Related]
26. Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population.
Mahmoud RAA; Amr NH; Toaima NN; Kamal TM; Elsedfy HH
J Endocrinol Invest; 2022 Feb; 45(2):347-359. PubMed ID: 34341969
[TBL] [Abstract][Full Text] [Related]
27. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
[TBL] [Abstract][Full Text] [Related]
28. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.
Barbaro M; Lajic S; Baldazzi L; Balsamo A; Pirazzoli P; Cicognani A; Wedell A; Cacciari E
J Clin Endocrinol Metab; 2004 May; 89(5):2402-7. PubMed ID: 15126570
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan.
Tajima T; Fujieda K; Nakae J; Mikami A; Cutler GB
Endocr J; 1998 Aug; 45(4):493-7. PubMed ID: 9881898
[TBL] [Abstract][Full Text] [Related]
30. [Identification of point mutations in the 21-hydroxylase gene in patients affected with congenital adrenal hyperplasia].
Fonseca D; Gutiérrez A; Silva C; Coll M; Malo G; Orjuela C; Arteaga C; Giraldo A
Biomedica; 2005 Jun; 25(2):220-30. PubMed ID: 16022377
[TBL] [Abstract][Full Text] [Related]
31. How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.
L'Allemand D; Tardy V; Grüters A; Schnabel D; Krude H; Morel Y
J Clin Endocrinol Metab; 2000 Dec; 85(12):4562-7. PubMed ID: 11134109
[TBL] [Abstract][Full Text] [Related]
32. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Deneux C; Tardy V; Dib A; Mornet E; Billaud L; Charron D; Morel Y; Kuttenn F
J Clin Endocrinol Metab; 2001 Jan; 86(1):207-13. PubMed ID: 11232002
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan.
Tajima T; Fujieda K; Nakae J; Toyoura T; Shimozawa K; Kusuda S; Goji K; Nagashima T; Cutler GB
J Clin Endocrinol Metab; 1997 Jul; 82(7):2350-6. PubMed ID: 9215318
[TBL] [Abstract][Full Text] [Related]
34. Five patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (one with associated neuroblastoma) discovered in three generations of one family.
Janjanin N; Dumic M; Skrabic V; Kusec V; Grubic Z; Spehar Uroic A
Horm Res; 2007; 67(3):111-6. PubMed ID: 17057407
[TBL] [Abstract][Full Text] [Related]
35. Frequency of CYP21 gene mutations in Czech patients with steroid 21-hydroxylase deficiency and statistical comparison with other populations.
Kotaska K; Průsa R
Med Princ Pract; 2003; 12(4):243-7. PubMed ID: 12966197
[TBL] [Abstract][Full Text] [Related]
36. 21-hydroxylase genotyping in Australasian patients with congenital adrenal hyperplasia.
Jeske YW; McGown IN; Harris M; Bowling FG; Choong CS; Cowley DM; Cotterill AM
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):127-41. PubMed ID: 19449670
[TBL] [Abstract][Full Text] [Related]
37. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.
Robins T; Carlsson J; Sunnerhagen M; Wedell A; Persson B
Mol Endocrinol; 2006 Nov; 20(11):2946-64. PubMed ID: 16788163
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic challenges in a patient with the simple virilizing (SV) form of congenital adrenal hyperplasia (CAH) due to the P30L/I172N genotype.
Tankoska M; Anastasovska V; Krstevska-Konstantinova M; Naydenov M; Kocova M
J Pediatr Endocrinol Metab; 2019 May; 32(5):543-547. PubMed ID: 31026224
[TBL] [Abstract][Full Text] [Related]
39. CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency.
Balsamo A; Cicognani A; Baldazzi L; Barbaro M; Baronio F; Gennari M; Bal M; Cassio A; Kontaxaki K; Cacciari E
J Clin Endocrinol Metab; 2003 Dec; 88(12):5680-8. PubMed ID: 14671153
[TBL] [Abstract][Full Text] [Related]
40. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations.
Nimkarn S; Cerame BI; Wei JQ; Dumic M; Zunec R; Brkljacic L; Skrabić V; New MI; Wilson RC
J Clin Endocrinol Metab; 1999 Jan; 84(1):378-81. PubMed ID: 9920112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
